Welcome to O2H
 
 
Welcome to O2H
O2h attending JP Morgan 28th Annual Healthcare conference

San Francisco, USA, 11-14 January 2010

 

O2h at Franco-British Business Exchange on Oncology

Lyon, France, 1-3 March 2010 
Contact us to arrange a meeting.
 
O2h Attending BIO Spring
Barcelona, Spain, 8-10 March 2010 
 
O2h present at the Biotrinity 2010
Oxford, UK, 2-3 April 2010

 

O2h attending MedChem Europe 2010 
Munich, Germany, 8-9 April 2010 
 
O2h attending the Anglonordic Biotech Conference 2010 
London, UK, 15 April 2010
 
O2h exhibiting at ERBI conference 2010 
Cambridge, UK, 2-3 June 2010 
 
O2h attending ChemPharma Outsourcing 2010 
New Jersey, USA, 14-16 September 2010 
 
New User Register
Medicinal Chemistry
O2h has a wide range of expertise in medicinal chemistry to help accelerate the drug discovery process. O2h can provide medicinal chemistry input to hit-to-lead and lead optimisation projects as well as at the pre-clinical developmental stage. Specifically, the O2h team has demonstrated expertise in:
 
Lead Generation
 
Ligand design for pre-defined targets
Synthesis of a homologous or diverse series of compounds for drug discovery projects
Design and generation of libraries of structurally related compounds (close structural analogs, bioisosters etc.)
Combinatorial synthesis of general as well as focused libraries
Quick search for surrogates of core chemical scaffold.
 
Lead Optimization and Structure Activity Relationship (SAR) studies
 
Hit-to-lead and Lead optimization with consideration of prior art, patentability and other IP issues
Computational chemistry and molecular modeling for the design of ligands
Design of virtual library with chemical diversity
Establishing structure-activity relationships
Prioritizing compounds for in-vitro screening
Generation of lead molecules using traditional/iterative medicinal chemistry approach
 
 
Oxygen Healthcare Ltd   23, Cambridge Science park, CB4 0EY , UK   Tel : +44 (0) 1223 437014   info@o2h.com
Sitemap